Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elevance Health, Inc. Common Stock (NY:ELV)

293.55 +4.82 (+1.67%)
Official Closing Price Updated: 4:10 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elevance Health, Inc. Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
19 20 Next >
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2024 Results on April 18, 2024
From Elevance Health, Inc.
Via Business Wire
Israel Kills Top Iranian General – Oil Rises – Not Great For Stock Market's No Inflation Story
To gain an edge, this is what you need to know today. Raise Hedges It is time to raise hedges.  As full disclosure, a signal was given to The Arora Report members. 
Via Benzinga
Topics Economy
UnitedHealth, Health Insurers Tumble On Medicare Advantage Rates
Final Medicare Advantage rates were unchanged vs. the initial proposal. 
Via Investor's Business Daily
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
 
Via Benzinga
How Is The Market Feeling About Elevance Health?
 
Via Benzinga
$100 Invested In Elevance Health 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Analyst Scoreboard: 6 Ratings For Elevance Health
 
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,500 Today
 
Via Benzinga
How Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows
Study reveals stark contrast: Novo Nordisk's Ozempic diabetes drug costs nearly $1,000 monthly in the U.S., yet could be produced for less than $5. This underscores the affordability challenge faced by... 
Via Benzinga
Insurance Coverage For Weight Loss Drugs - Elevance, CVS Health Become First To Extend Coverage To Novo Nordisk's Successful Wegovy For Certain Patients
Major U.S. health insurers CVS Health, Elevance Health, and Kaiser Permanente now reimburse for Novo Nordisk's Wegovy for specific Medicare individuals with heart-related conditions. This shift aims to... 
Via Benzinga
3 Stocks To Buy For Decreased Volatility
Here are three low-beta stocks that could all be considered for those looking for a more conservative approach. 
Via Talk Markets
3 Stocks To Buy For Decreased Volatility
Beta measures a stock's volatility in comparison to a relevant benchmark. The market, such as the S&P 500 Index, has a beta of 1.0. 
Via Talk Markets
Topics Stocks
Kroger Passes The Baton: Sells Specialty Pharmacy Division To CarelonRx
Kroger sells specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health, for undisclosed amount. Deal expected to close in 2nd half of 2024, will not impact 2024 guidance. 
Via Benzinga
Peeling Back The Layers: Exploring Elevance Health Through Analyst Insights
 
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,200 Today
 
Via Benzinga
Here's How Much $1000 Invested In Elevance Health 20 Years Ago Would Be Worth Today
 
Via Benzinga
Elevance Health Announces Closing of Paragon Healthcare Acquisition
From Elevance Health, Inc.
Via Business Wire
Healthcare Needs Will Soar As The Population Grows Older, Presenting A Profit Opportunity
The aging of our society puts new demands on our economy. A smaller number of working-age people will be expected to support a larger group of older folks who have left the labor force. 
Via Talk Markets
Topics Economy
Elevance Health Announces Appearance at the Cowen 44th Annual Health Care Conference
From Elevance Health, Inc.
Via Business Wire
Elevance Health Announces Appearance at Barclays 26th Annual Global Healthcare Conference
From Elevance Health, Inc.
Via Business Wire
Navigating 4 Analyst Ratings For Elevance Health
 
Via Benzinga
Elevance Health Named in Top 10 of America’s Most JUST Companies by JUST Capital and CNBC
From Elevance Health, Inc.
Via Business Wire
5 top healthcare stocks for earnings growth in 2024
2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed. 
Via MarketBeat
Elevance Health (ELV) Q4 2023 Earnings Call Transcript
ELV earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Health Insurer Elevance's Q4 Earnings: Dividend Increase, Drop In Medicaid Enrollment, Upbeat 2024 Outlook
Elevance Health excels with Q4 2023 revenues of $42.45B, up 7% YoY, surpassing consensus. Explore the growth drivers, profit insights, and future projections. 
Via Benzinga
Preview: Elevance Health's Earnings
 
Via Benzinga
Looking Into Elevance Health's Recent Short Interest
 
Via Benzinga
Elevance Health Reports Results for Fourth Quarter and Full Year 2023; Sets Full Year 2024 Outlook
From Elevance Health, Inc.
Via Business Wire
Earnings Scheduled For January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion. 
Via Benzinga
S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?
US stocks rise to record highs on strong earnings reports, with small caps outperforming. Dollar steady, gold down, oil up. Bitcoin tumbles. AMD, TSLA, ADM, GILD, WDC top movers. GE, AAPL, FB, AMZN,... 
Via Benzinga
Topics Stocks
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.